Search Results

Containing any of the words

Only of the type

Enalapril Risk Minimization Activity - New

" A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer" Drug Clinical Trial

An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease Drug Clinical Trial

Multicenter, open-label, study to evaluate safety,tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared with enalapril in pediatric patients from1 month to < 18 years of age with heart failure due to systemic left ventricle systolic dysfunction) Drug Clinical Trial

SFDA Participates in World Food Safety Day Under the Theme “Food Standards Save Lives” News

Hajj Awareness Article

Salicylic Acid or Benzoyl Peroxide Risk Minimization Activity - New

Guidance on MDMA –Significant and Non-Significant Changes (MDS-G012) Regulations

Guidance on Manufacturing Paths of Medical Devices (MDS-G011) Regulations

SERIOUS SAFETY CONCERNS WITH THE ASTHMA MEDICATIONS SERETIDE, SYMBICORT, SEREVENT, FORADIL Awareness Article